BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 6, 2017
View Archived Issues
AVROBIO licenses cystinosis program from Genstem Therapeutics
Read More
CD36 is a promising drug target for treating T2DM
Read More
Board recommends continuing Athenex's phase III Oraxol 001 study
Read More
Sirtuin-6 could be modulated to prevent NASH progression
Read More
FDA gives orphan drug status to CytoDyn's PRO-140
Read More
PCI Biotech's fimaporfin wins orphan drug status in U.S.
Read More
Kyowa Hakko Kirin doses first patient in phase II trial of entinostat
Read More
Aerie Pharmaceuticals acquires rights to PRINT technology in ophthalmology
Read More
Monoclonal antibodies developed to target both dengue and Zika viruses
Read More
FDA accepts Methylene Blue MMX NDA
Read More
Immatics closes USD 58 million series E financing
Read More
EMA accepts Cinfa's MAA for biosimilar pegfilgrastim B-12019
Read More
Emory University patents antiviral compounds for hepatitis B, hepatitis C and West Nile viruses
Read More
The University of California, Oakland presents novel apoptosis inducers and splicing modulators
Read More
STAT3-targeting antibody SBT-100 given U.S. orphan drug designation
Read More
GlaxoSmithKline identifies novel integrin alphavbeta6 receptor antagonists
Read More
Novel oligopeptides created at Guangzhou Nuowei Biotechnology
Read More
AstraZeneca identifies new serine-protein kinase ATM inhibitors
Read More
FDA approves cobas Zika test to screen blood donations
Read More
Zealand establishes research collaboration with Torrey Pines Institute for Molecular Studies
Read More
Acadia Pharmaceuticals starts phase III HARMONY trial of Nuplazid
Read More
KemPharm and Genco sign licensing agreement to develop prodrug for pediatric Tourette's with ADHD
Read More
Phase III TIVO-3 trial of Fotivda to continue as planned following futility analysis
Read More
Role of CD36 in islet dysfunction makes it a target for treating diabetes
Read More
AOBiome begins enrollment in phase Ib/IIa of AOB product for SAR
Read More